INNZ MEDICAL ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  8.3% 11.0% 6.5% 4.5% 6.0%  
Credit score (0-100)  31 22 35 46 37  
Credit rating  BB BB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  2,218 2,494 3,434 3,650 3,132  
EBITDA  120 28.3 827 829 184  
EBIT  119 28.3 827 829 184  
Pre-tax profit (PTP)  103.7 -20.3 798.0 755.9 -51.1  
Net earnings  77.6 -22.9 616.3 572.3 -93.0  
Pre-tax profit without non-rec. items  104 -20.3 798 756 -51.1  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 0.0 39.3  
Shareholders equity total  271 249 865 837 244  
Interest-bearing liabilities  622 313 893 14.9 2,827  
Balance sheet total (assets)  3,046 3,553 5,979 3,990 5,768  

Net Debt  112 158 352 -356 2,407  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  2,218 2,494 3,434 3,650 3,132  
Gross profit growth  38.2% 12.4% 37.7% 6.3% -14.2%  
Employees  4 4 4 4 4  
Employee growth %  100.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  3,046 3,553 5,979 3,990 5,768  
Balance sheet change%  93.4% 16.7% 68.2% -33.3% 44.6%  
Added value  119.6 28.3 826.5 828.9 184.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -2 0 0 0 39  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  5.3% 1.1% 24.1% 22.7% 5.9%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  5.1% 0.9% 17.3% 16.6% 3.8%  
ROI %  12.1% 3.4% 62.8% 56.6% 8.6%  
ROE %  33.4% -8.8% 110.7% 67.3% -17.2%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  8.9% 7.0% 14.5% 21.0% 4.2%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  93.9% 558.3% 42.6% -42.9% 1,305.3%  
Gearing %  229.1% 126.1% 103.2% 1.8% 1,158.0%  
Net interest  0 0 0 0 0  
Financing costs %  2.1% 10.4% 4.7% 16.1% 16.5%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.7 0.5 0.8 0.6 0.4  
Current Ratio  1.1 1.1 1.2 1.3 1.1  
Cash and cash equivalent  509.7 155.2 540.7 370.5 419.5  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  329.2 404.5 1,024.0 995.6 374.2  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  30 7 207 207 46  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  30 7 207 207 46  
EBIT / employee  30 7 207 207 46  
Net earnings / employee  19 -6 154 143 -23